GNPX Congressional Stock Trades

Genprex, Inc.

Last disclosed trade Feb 5

Every disclosed trade in GNPX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every healthcare stock Congress trades.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Tim Moore · Bought $GNPX · Oct 29 · $15K–$50K

0.55MED

Disclosure speedx 0.250.60

Trade sizex 0.250.50

Cluster activityx 0.150.00

Track recordx 0.350.77

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $GNPX

Get notified when any member of Congress trades $GNPX. Free, no card, no spam.

Follow free →

Disclosed trades

Buys

Sales

Members trading

The record on $GNPX

Coldpine has parsed 4 disclosed trades in $GNPX by 1 member of Congress, drawn from 4 periodic transaction reports dated Oct 29, 2025 through Feb 5, 2026. All of them came from House members, all filed by Republicans.

Of the 4 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 18 days. The longest was 25 days: a $GNPX purchase by Tim Moore dated Nov 7, 2025, disclosed Dec 2, 2025. How late filing is measured across all of Congress is in the late-filers study.

Members who trade GNPX

Tim Moore4

Recent disclosed trades in GNPX

Date	Member	Type	Amount
Feb 5	Tim Moore(NC)	buy	$1K–$15K
Dec 18	Tim Moore(NC)	buy	$1K–$15K
Nov 7	Tim Moore(NC)	buy	$1K–$15K
Oct 29	Tim Moore(NC)	buy	$15K–$50K

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →